Bhandari Homoeopths Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 34 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.45 M
- Revenue Growth -14.31%
- Profit Growth -213.71%
- Ebitda -76.78%
- Net Worth -0.01%
- Total Assets -1.39%
About Bhandari Homoeopths
Bhandari Homoeopths Private Limited (BHPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 July 1990 and has a history of 34 years and seven months. Its registered office is in Alwar, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹2.45 M.
Sandeep Bhandari, Krishan Bhandari, and Pushpa Bhandari serve as directors at the Company.
Company Details
-
Location
Alwar, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24234RJ1990PTC005470
-
Company No.
005470
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jul 1990
-
Date of AGM
25 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Bhandari Homoeopths?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishan Bhandari
|
Director | 03-Jul-1990 | Current |
|
Sandeep Bhandari
|
Director | 03-Jul-1990 | Current |
|
Pushpa Bhandari
|
Director | 22-Aug-2017 | Current |
Financial Performance of Bhandari Homoeopths.
Bhandari Homoeopths Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 14.31% decrease. The company also saw a substantial fall in profitability, with a 213.71% decrease in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhandari Homoeopths?
In 2017, Bhandari Homoeopths had a promoter holding of 86.76% and a public holding of 13.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.45 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Feb 2007 | Bank Of Baroda | ₹2.45 M | Open |
How Many Employees Work at Bhandari Homoeopths?
Unlock and access historical data on people associated with Bhandari Homoeopths, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhandari Homoeopths, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhandari Homoeopths's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.